Archive: 31/03/2015

FDA expands approval for 'valve in valve' aortic replacement

(HealthDay)—The U.S. Food and Drug Administration said Tuesday that use of the CoreValve "valve-in-valve" aortic replacement has been expanded to include people at extreme risk for serious complications of traditional open-heart ...

page 3 from 9